Gustavo Simao Moraes
Overview
Explore the profile of Gustavo Simao Moraes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugio C, Cestari T, Garcia A, Moraes G, Albach T, de Oliveira T, et al.
J Med Microbiol
. 2024 Oct;
73(10).
PMID: 39392377
Tissue conditioners modified with antifungals are a potential alternative to denture stomatitis (DS) treatment. Information on tissue response to this treatment before its clinical application is lacking. This study aimed...
2.
Moraes G, Albach T, Sugio C, Cachoeira V, Kiratcz F, Tozetto N, et al.
J Appl Microbiol
. 2024 May;
135(6).
PMID: 38744659
Aim: This study investigated the effectiveness of a drug-modified tissue conditioner in an animal model of denture stomatitis. Methods And Results: Wistar rats wore a Candida albicans-contaminated palatal device for...
3.
Moraes G, Tozetto N, Pedroso T, de Mattos M, Urban A, Paludo K, et al.
J Appl Toxicol
. 2024 Jan;
44(5):747-755.
PMID: 38198744
The emergence of resistant fungal species and the toxicity of currently available antifungal drugs are relevant issues that require special consideration. Cyclodextrins inclusion complexes could optimize the antimicrobial activity of...
4.
Schoeffel A, Morikava F, Urban A, Novatski A, Moraes G, Matioli G, et al.
Ther Deliv
. 2023 Jul;
14(4):295-309.
PMID: 37401351
This study aimed to develop, characterize and analyze the antifungal activity of chlorhexidine:β-cyclodextrin inclusion complexes (Chx:βCD). Chx:βCD were characterized by physicochemical techniques and the susceptibility of nine strains was assessed....
5.
Moraes G, Albach T, Sugio C, Cachoeira V, Kiratcz F, Claudino M, et al.
Med Mycol
. 2022 Nov;
60(12).
PMID: 36441017
This study compared different conditions to establish a rat model of denture stomatitis. Immunocompetent Wistar rats were divided into two groups (n = 35): Tetracycline = administration of 0.83 mg/ml...
6.
Urban A, Morikava F, Schoeffel A, Novatski A, Moraes G, Cachoeira V, et al.
Curr Drug Deliv
. 2022 Oct;
20(10):1533-1546.
PMID: 36263476
Background: Nystatin (Nys) is a fungicidal drug commonly prescribed for candidiasis disease in several administration routes. However, Nys is a class IV drug, according to the Biopharmaceutical Classification System, that...
7.
Moraes G, Albach T, Ramos I, Kopacheski M, Cachoeira V, Sugio C, et al.
J Appl Oral Sci
. 2021 Apr;
29:e20200865.
PMID: 33886943
Objective: This study describes a protocol to obtain and to contaminate a palatal device with Candida albicans biofilm that could be used for an animal model of denture stomatitis. Methodology:...
8.
Sugio C, Garcia A, Albach T, Moraes G, Bonfante E, Urban V, et al.
J Fungi (Basel)
. 2020 May;
6(2).
PMID: 32456172
Considering the high prevalence and recurrence of Candida-associated denture stomatitis (CADS), in vivo studies in animal models are necessary before those in humans to evaluate new therapeutic strategies. This study...
9.
Moraes G, Santos I, Pinto S, Pochapski M, Farago P, Pilatti G, et al.
J Appl Oral Sci
. 2019 Nov;
28:e20190025.
PMID: 31778442
Introduction: Periodontal therapy usually requires local anesthesia. If effective, a non-invasive, liposomal anesthetic gel could increase the levels of acceptance of patients in relation to periodontal therapy. Objective: This study...